Model:7501142911306
Current Reviews:0
Price:$33.00
Azulfidine 500mg 60 Tabs Sulfasalazine
THIS IS A BRAND MEDICATION
INDICATIONS: Sulfasalazine, in his presentation of EN-tabs, is indicated in the systemic treatment of inflammatory bowel diseases (eg ulcerative colitis, Crohn's disease).
The tablets of enteric-coated sulphasalazine-EN-tabs-are indicated in the systemic treatment of:
• Rheumatoid arthritis in adults.
• pauciarticular and polyarticular course of juvenile rheumatoid arthritis.
CONTRAINDICATIONS: Azulfidine ® is contraindicated in:
• Hypersensitivity to sulfasalazine, its metabolites, sulfonamides or salicylates.
• Patients with porphyria.
PRECAUTIONS: Sulfasalazine should not be given to patients with impaired hepatic or renal function or with blood dyscrasias, unless the potential benefits outweigh possible risks.
The presence of clinical signs such as sore throat, fever, pallor, purpura or jaundice during treatment with sulfasalazine may indicate bone marrow suppression, hemolysis, or hepatotoxicity.Discontinuing treatment with sulfasalazine while you are waiting for blood test results.
Oral administration of sulfasalazine inhibits the absorption and metabolism of folic acid and can cause folic acid deficiency, which can potentially lead to serious blood disorders (eg macrocytosis and pancytopenia).
As with other sulfonamides, sulfasalazine may cause haemolysis in patients deficient in the enzyme glucose-6-phosphate dehydrogenase.
Sulfasalazine should be provided with caution in patients with severe pictures allergy or bronchial asthma.
Since sulfasalazine causes crystalluria and kidney stones, you must maintain an adequate fluid intake.
The use in children with systemic onset juvenile rheumatoid arthritis may result in a reaction similar to serum sickness, therefore, not recommended the use of sulfasalazine in this class of patients.
Oligospermia and infertility may occur in men treated with sulfasalazine. Discontinuation of the drug, apparently reverses these effects after 2-3 months.
DOSAGE AND ADMINISTRATION: Oral.
The dosage of sulfasalazine should be adjusted to each individual according to patient tolerability of the drug and response to treatment.
Systemic treatment of inflammatory bowel disease to sulfasalazine EN-tabs *
Active disease
Maintenance of remission
Adults (including elderly)
Initiating therapy with 1 to 2 g / day in 3 equally divided doses or more. Gradually increased to a dose of 3 to 8 g / day.
2 to 3 g / day in 3 equally divided doses or more.
Active disease
Maintenance of remission
Children (6 years and older)
40 to 150 mg / kg / day in 3 equally divided doses or more.
20 to 75 mg / kg / day in 3 equally divided doses or more.
* EN-tabs Tablets should be swallowed intact, preferably after meals, and should not be chewed or milled.
Systemic treatment of adult and juvenile rheumatoid arthritis and polyarticular pauciarticular sulphasalazine EN-tabs *
Dosage
Adults (including elderly)
The initial dose is 500 mg / day, with increments of 500 mg each week up to 2 g / day given in 2 to 4 doses.
May require treatment for 12 weeks in some patients before clinical benefit is observed. The daily dose may be increased to 3 g if the clinical response observed after 12 weeks is inadequate, however, we recommend careful monitoring of doses above 2 g / day.
Children (6 years or more)
30 to 75 mg / kg / day in 2 equal doses. Generally, the maximum dose is 2 g / day. To reduce possible gastrointestinal intolerance, start with one quarter to one third of the planned dose for the maintenance and conduct weekly increments until reaching the maintenance dose in a month.
* EN-tabs Tablets should be swallowed intact, preferably after meals, and should not be chewed or milled.
Name of the medication: Azulfidine
Comparative brand name: Azulfidine
Active substance: Sulfasalazina
Presentation: Tablets
Concentration:500mg
Time release: No
Laboratory: Pfizer, S.A. de C.V
Box with 60 Tablets
Made in: Mexico
